Drug Bioequivalence

Description:

Report of the findings from a panel of the Office of Technology Assessment (OTA) regarding drug bioequivalence therapies. According to the report, the purpose of the Drug Bioequivalence Study Panel "was to examine the relationships between the chemical and therapeutic equivalence of drug products and to assess the capability of current technology -- short of therapeutic trials in man -- to determine whether drug products with the same physical and chemical composition produce comparable therapeutic effects" (p. 5).

Creator(s): United States. Congress. Office of Technology Assessment. Drug Bioequivalence Study Panel.
Location(s): United States
Creation Date: July 1974
Partner(s):
UNT Libraries Government Documents Department
Collection(s):
Office of Technology Assessment
Usage:
Total Uses: 120
Past 30 days: 1
Yesterday: 0
Creator (Author):
Publisher Info:
Date(s):
  • Creation: July 1974
Coverage:
Place
United States
Date
1974  
Description:

Report of the findings from a panel of the Office of Technology Assessment (OTA) regarding drug bioequivalence therapies. According to the report, the purpose of the Drug Bioequivalence Study Panel "was to examine the relationships between the chemical and therapeutic equivalence of drug products and to assess the capability of current technology -- short of therapeutic trials in man -- to determine whether drug products with the same physical and chemical composition produce comparable therapeutic effects" (p. 5).

Note:

The original does not have a page 4.

Physical Description:

78 p. ; 28 cm.

Language(s):
Subject(s):
Keyword(s): standards | drug policies | drug therapies | drug trials | bioequivalency
Partner:
UNT Libraries Government Documents Department
Collection:
Office of Technology Assessment
Identifier:
  • ARK: ark:/67531/metadc39335
Resource Type: Report
Format: Text